Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers

FOUNDATION FOR SICKLE CELL DISEASE RESEARCH

NPI: 1053720243 · HOLLYWOOD, FL 33023 · Internal Medicine Physician · NPI assigned 08/12/2014

$1.97M
Total Medicaid Paid
262,922
Total Claims
32,317
Beneficiaries
43
Codes Billed
2020-01
First Month
2024-11
Last Month

Provider Details

Authorized OfficialBRONTE, LANETTA (PRESIDENT AND CEO)
NPI Enumeration Date08/12/2014

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2020 8,256 $90K
2021 20,345 $244K
2022 93,376 $562K
2023 85,135 $589K
2024 55,810 $487K

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour 7,179 967 $375K
99213 Office or other outpatient visit for the evaluation and management of an established patient, low complexity 15,321 1,783 $293K
96361 Intravenous infusion, hydration; each additional hour 17,288 1,801 $249K
93000 13,437 1,856 $218K
96375 Therapeutic injection; each additional sequential IV push 18,616 1,853 $180K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance 17,037 1,796 $117K
85018 12,312 1,669 $94K
82962 13,998 1,830 $57K
81002 9,222 1,210 $54K
99214 Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 3,728 668 $51K
36415 Collection of venous blood by venipuncture 803 257 $43K
J1170 Injection, hydromorphone, up to 4 mg 13,254 1,207 $43K
J1885 Injection, ketorolac tromethamine, per 15 mg 8,840 1,187 $40K
85048 10,753 1,300 $26K
99215 Prolong outpt/office vis 1,031 224 $24K
J0131 Injection, acetaminophen, not otherwise specified,10 mg 4,379 642 $18K
J2405 Injection, ondansetron hydrochloride, per 1 mg 13,438 1,581 $13K
81025 9,766 1,268 $13K
J2270 Injection, morphine sulfate, up to 10 mg 1,233 212 $12K
81003 8,643 1,004 $11K
96376 1,303 102 $8K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour 609 131 $7K
J7070 Infusion, d5w, 1000 cc 2,586 560 $4K
85027 3,269 480 $4K
85025 Blood count; complete (CBC), automated, and automated differential WBC count 2,782 394 $4K
J1200 Injection, diphenhydramine hcl, up to 50 mg 16,445 1,785 $3K
J2175 Injection, meperidine hydrochloride, per 100 mg 366 72 $3K
82948 3,368 506 $3K
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit) 10,198 1,129 $2K
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward 120 90 $1K
J7060 5% dextrose/water (500 ml = 1 unit) 2,040 325 $806.23
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe 21 18 $568.40
94010 52 31 $383.44
96127 439 140 $244.00
99491 Ccm add 20min 157 123 $115.56
J0895 Injection, deferoxamine mesylate, 500 mg 39 12 $70.27
36416 12,641 1,235 $50.90
G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) 304 188 $50.20
J1171 Injection, hydromorphone, 0.1 mg 226 71 $48.35
A4301 Implantable access total catheter, port/reservoir (e.g., venous, arterial, epidural, subarachnoid, peritoneal, etc.) 5,565 569 $13.48
J7030 Infusion, normal saline solution , 1000 cc 73 14 $1.99
99072 15 12 $0.00
G2064 Comprehensive care management services for a single high-risk disease, e.g., principal care management, at least 30 minutes of physician or other qualified health care professional time per calendar month with the following elements: one complex chronic condition lasting at least 3 months, which is the focus of the care plan, the condition is of sufficient severity to place patient at risk of hospitalization or have been the cause of a recent hospitalization, the condition requires development or revision of disease-specific care plan, the condition requires frequent adjustments in the medication regimen, and/or the management of the condition is unusually complex due to comorbidities 26 15 $0.00